(Q34750112)

4 August 2017

Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances (English)

1 reference

4 August 2017

Kai Hilpert

2

0 references

Robert E. W. Hancock

series ordinal

3

object named as

Robert E W Hancock

1 reference

4 August 2017

Irith Wiegand

1

1 reference

4 August 2017

1 January 2008

1 reference

4 August 2017

1 reference

4 August 2017

3

1 reference

4 August 2017

163-175

1 reference

4 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/nprot.2007.521

4 August 2017

0 references

cites work

European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

The effects of environmental conditions on the in vitro activity of selected antimicrobial agents against Escherichia coli

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Effect of Calcium and Magnesium Ions on the Susceptibility of Pseudomonas Species to Tetracycline, Gentamicin Polymyxin B, and Carbenicillin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Reproducibility of daptomycin MIC results using dry-form commercial trays with appropriate supplemental calcium content

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

A re-evaluation of the role of host defence peptides in mammalian immunity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Effect of NaCl and nafcillin on penicillin-binding protein 2a and heterogeneous expression of methicillin resistance in Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Methicillin-resistant staphylococci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

False susceptibility of Klebsiella oxytoca to some extended-spectrum cephalosporins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Validation of Etest for seven antimicrobial agents using regulatory criteria for the assessment of antimicrobial susceptibility devices.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Comparison of the Etest with a conventional agar dilution method in evaluating the in vitro activity of moxifloxacin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Comparison of Etest, agar dilution, broth microdilution and disk diffusion methods for testing in vitro activity of levofloxacin against Staphylococcus spp. isolated from neutropenic cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Comparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using gram-positive organisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Determination of minimum inhibitory concentrations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

Influence of antibiotic stability on the results of in vitro testing procedures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2007.521

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NPROT.2007.521

1 reference

PubMed ID

18274517

Dimensions Publication ID

4 August 2017

0 references

1 reference

PubMed ID

18274517